Description de l'entreprise
BB Biotech invests in companies in the fast growing market of biotechnology and is one of the world’s largest investors in this sector. BB Biotech is listed in Switzerland, Germany and Italy. Its investments are focused on listed companies that are developing and commercializing novel medical treatments and cures. BB Biotech’s investment selection process is guided by the fundamental research and analysis of physicians and molecular biologists. Its Board of Directors has many years of experience in industry and science.
Conseil d'administration & Conseil de surveillance
| PDG |
| Dr. Daniel Koller |
| Conseil d'administration |
| Dr. Thomas von Planta, Laura Hamill, Dr. Pearl Huang, Prof. Dr. Mads Krogsgaard Thomsen, Camilla Soenderby |
| Conseil de surveillance |
| Dr. Clive Meanwell |
Données de l'entreprise
| Nom: |
BB Biotech AG |
| Adresse: |
Schwertstraße 6,CH-8200 Schaffhausen/Schweiz |
| Téléphone: |
+41-52-624-0845 |
| Fax: |
- |
| Courriel: |
info@bbbiotech.com
|
| Internet: |
www.bbbiotech.com |
| Industrie: |
Financial |
| Secteur: |
Specialty Finance |
| Sous-secteur: |
Diversified Financial |
| Fin de l'exercice financier: |
31/12 |
| Flotte libre: |
97.00% |
| IPO date: |
10/12/1997 |
Relations avec les investisseurs
| Nom: |
Dr. Silvia Siegfried-Schanz |
| Téléphone IR: |
+41-44-267-7266 |
| IR-Fax: |
- |
| E-mail IR: |
ssc@bellevue.ch
|
